IAS-USAInternational AIDS Society-USA
References in periodicals archive ?
Darunavir-specific resistance mutations listed by the December 2008 IAS-USA panel update were considered.
The patients with [greater than or equal to] 3 DRV-specific resistance mutations had a mean total number of protease resistance mutations from the IAS-USA list of 13.
The recommendations of the IAS-USA panel are made in the context of other recommendations from yet another group of experts, namely the Panel on Clinical Practices for Treatment of HIV Infection.
The IAS-USA panel's premature endorsement of resistance testing is also not without opportunity costs.